Close
ACHEMA MIDDLE EAST 2026
17TH Global Drug Delivery & Formulation Summit 2026

Facilities & Operation

      Eisai Launches New Oral Suspension Formulation For Antiepileptic Drug Fycompa In The USA

      Facilities & Operation
      As Adjunctive Therapy for the Treatment of Partial-Onset Seizures and Primary Generalized Tonic-Clonic Seizures in Patients with Epilepsy   Eisai Co Ltd announced that...

      Actelion’s Uptravi Now Available In Germany To Treat Pulmonary Arterial Hypertension

      Facilities & Operation
      Actelion announced the commercial availability of the oral, selective, IP prostacyclin receptor agonist, Uptravi® (selexipag) for the treatment of pulmonary arterial hypertension (PAH) in...

      Promising Excipient&Dosage Market and Rigid Social Demand for BPCs

      Facilities & Operation
      CPhI China, hosted by UBM EMEA and China Chamber of Commerce of Medicines & Health Products Importers & Exporters and co-organized by UBM...

      Grasp the opportunity at Emerging Markets for High Growth of Life Science and Chemical Instrumentation

      Facilities & Operation
      The global life science and chemical instrumentation market will reach USD48.84 billion by 2019, with the compound average growth rate of 6.9%. Geographically, North...

      Merck Provides Update on European Medicines Agency Marketing Authorization Application for Investigational Chronic Hepatitis C Therapy Elbasvir/Grazoprevir

      Facilities & Operation
      Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the Committee for Medicinal Products for Human Use (CHMP) of...

      New Analyses Further Add to the Efficacy and Safety Profile of OFEV® (nintedanib) in Idiopathic Pulmonary Fibrosis (IPF)

      Facilities & Operation
      First data from post-marketing surveillance was consistent with the safety profile of OFEV® from the clinical studies supporting its FDA approvalIn two separate post-hoc...

      Real-World Analysis of more than 44,000 Patients Reinforces Safety and Effectiveness of Pradaxa® in Routine Clinical Care

      Facilities & Operation
      Brigham and Women’s Hospital in Boston, U.S., and Boehringer Ingelheim announce the results of a new interim analysis from a long-term study evaluating the...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.